Harrow HROW
NASDAQ HROW
$37.54 -0.31 (-0.82%)
As of: Sep 9, 2026 · 3:14 PM EDT

Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020)

Harrow (HROW) posted Non-Current Deferred Tax Liability of $274000.0 for Q4 2020, up 1.48% on a QoQ basis from $270000.0 in Q4 2019, and up 1.48% year-over-year from $270000.0 in Q1 2020.

Analysis

Harrow (HROW) Non-Current Deferred Tax Liability (2015 - 2020) Analysis & Trends

Harrow has reported Non-Current Deferred Tax Liability for 5 years, with the latest figure at $274000.0 in Q4 2020.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 1.48% year-over-year to $274000.0 in Q4 2020; TTM through Dec 2020 was $274000.0, a 1.48% increase from a year earlier, with the FY2020 full-year figure at $274000.0, up 1.48% from the prior year.
  • Non-Current Deferred Tax Liability was $274000.0 for Q4 2020 at Harrow, up from $270000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $1.0 million in Q1 2016, with the low at $270000.0 in Q4 2019.
  • Average Non-Current Deferred Tax Liability over 4 years is $806777.8, with a median of $908000.0 recorded in 2017.
  • The sharpest annual moves came in 2017 and 2020: Non-Current Deferred Tax Liability decreased 18.62% in 2017, then rose 1.48% in 2020.
  • Over 4 years, Non-Current Deferred Tax Liability stood at $936000.0 in 2016, then declined by 8.97% to $852000.0 in 2017, then slumped by 68.31% to $270000.0 in 2019, then grew by 1.48% to $274000.0 in 2020.
  • The last three Non-Current Deferred Tax Liability figures came in at $274000.0 (Q4 2020), $270000.0 (Q4 2019), and $852000.0 (Q3 2017), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn
2 AbbVie 442.18 Bn 435.61 Bn 12.70 Bn
3 Merck 366.59 Bn 359.45 Bn 12.21 Bn
4 Novartis Ag 266.49 Bn 258.80 Bn 11.24 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn
6 Sanofi 52.34 Bn 44.96 Bn 10.79 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn
10 Harrow 1.40 Bn 1.32 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 274,000.00
Dec 31, 2019 270,000.00
Sep 30, 2017 852,000.00
Jun 30, 2017 880,000.00
Mar 31, 2017 908,000.00
Dec 31, 2016 936,000.00
Sep 30, 2016 1.05 Mn
Jun 30, 2016 1.05 Mn
Mar 31, 2016 1.05 Mn
Dec 31, 2015 1.05 Mn